Roundtable Discussion: How Are Investors, Pharma, & Partners Evaluating the Next Generation of Treg Companies?

3:00 pm - Thursday 25th March 2027

  • Evaluating the data packages investors and pharma seek following increasing clinical validation
  • Assessing which indications present the strongest commercial opportunities
  • Determining how clinical differentiation, manufacturing readiness, and regulatory strategy influence valuations